Evidence map›Paper›PMID 36768462›Full record

ReviewInternational journal of molecular sciences2023

Immunopharmacological Activities of Luteolin in Chronic Diseases.

Lei Huang, Mi-Yeon Kim, Jae Youl Cho

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed.

  1. Food science & nutrition · 2026
    Review
  2. Plants (Basel, Switzerland) · 2026
    Review
  3. Article
  4. Luteolin alleviates inflammation by inhibiting the PI3K-Akt-FOXO3a pathway.Naunyn-Schmiedeberg's archives of pharmacology · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Phytochemical Constituent of Devil Weed (Molecules (Basel, Switzerland) · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lei HuangDepartment of Biocosmetics, Sungkyunkwan University, Suwon 16419, Republic of Korea.
Mi-Yeon KimSchool of Systems Biomedical Science, Soongsil University, Seoul 06978, Republic of Korea.
Jae Youl ChoDepartment of Biocosmetics, Sungkyunkwan University, Suwon 16419, Republic of Korea.ORCID 0000-0001-8141-9927

Funding

National Research Foundation of Korea 2017R1A6A1A03015642
6 · The paper itself

Abstract

Flavonoids have been shown to have anti-oxidative effects, as well as other health benefits (e.g., anti-inflammatory and anti-tumor functions). Luteolin (3', 4', 5,7-tetrahydroxyflavone) is a flavonoid found in vegetables, fruits, flowers, and herbs, including celery, broccoli, green pepper, navel oranges, dandelion, peppermint, and rosemary. Luteolin has multiple useful effects, especially in regulating inflammation-related symptoms and diseases. In this paper, we summarize the studies about the immunopharmacological activity of luteolin on anti-inflammatory, anti-cardiovascular, anti-cancerous, and anti-neurodegenerative diseases published since 2018 and available in PubMed or Google Scholar. In this review, we also introduce some additional formulations of luteolin to improve its solubility and bioavailability.

Indexed as

FlavonoidsLuteolinAnti-Inflammatory AgentsChronic DiseaseHumansVegetablesAnti-Inflammatory AgentsFlavonoidsLuteolinbioinformatics analysiscancerchronic diseaseflavonoidin vitroin vivoluteolin

Identifiers

PMID36768462
PMCPMC9917216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.